Work

Abstract CT153: First in human phase 1 trial of the SRC family kinase inhibitor NXP900 in patients with advanced solid tumors

Year: 2025

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am2025-ct153

Authors: Gerald Falchook, Jordi Rodon Ahnert, Shivaani Kummar, Hani M. Babikar, Stefan Symeonides, Mitesh J. Borad, Jason Henry, J. Mark Sloan, Justin L. Hay, Megan Sardone, Udai Banerji

Institutions: HealthONE, The University of Texas MD Anderson Cancer Center, Oregon Health & Science University, Mayo Clinic in Florida, NHS Lothian, Western General Hospital, Mayo Clinic in Arizona, Boston University, Royal Marsden NHS Foundation Trust

Language: English

Topic: Cancer Mechanisms and Therapy

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4409821980

Cites:

Cited by: 2

Related to: 10